Filter posts

The Blunders of In Re Kubin

A recent U.S. Federal Circuit of Appeals decision (In Re Kubin) distorts the definition of …

BIO IP News Weekly for March 20, 2009

BIO’s weekly newsletter of stories compiled from a variety of public news sources, previously only …

US Court of Appeals for the Federal Circuit Issues Decision in Tafas v Dudas

Read the Decision here: http://tinyurl.com/ce6o7r Read BIO’s Comments to the US Patent and Trademark Office …

Monsanto Company: "Protect Innovation"

Read Monsanto Company’s guest blog post on innovation and patent reform on Patently-O Blog.

HHS Requests Public Comment on Draft Report on Gene Patents and Licensing Practices and Their Impact...

HHS Requests Public Comment on Draft Report on Gene Patents and Licensing Practices and Their …

Burrill Report's interview with BIO's President & CEO

Check out the new podcast on patent reform from Danny Levine of Burrill & Company …

Patent reform and Re-examination

Patent reform legislation was introduced in the House and Senate last week. Tell BIO what …

Tomorrow's Senate hearing on Patent Reform

Tomorrow morning, the Senate Judiciary Committee will hold its first 2009 hearing on patent reform. …

BIO President & CEO James Greenwood Hosts Media Briefing

Take a look at a recent post at one of PatentlyBIOtech’s sister blogs: www.biotech-now.org. Last week, …

Why Stop at Better? Let’s Strive For What’s Best (for Everyone)

BIO President and CEO Jim Greenwood responsed to a blog post on patent reform today. …